Leena Ylösmäki

7PUBLICATIONS
15CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 07, 2021
Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids.

Firas Hamdan, Erkko Ylösmäki, Jacopo Chiaro

|Jul 24, 2021
Therapeutic Cancer Vaccination with Immunopeptidomics-Discovered Antigens Confers Protective Antitumor Efficacy.

Karita Peltonen, Sara Feola, Husen M Umer

|Jul 16, 2021
Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin.

Erkko Ylösmäki, Manlio Fusciello, Beatriz Martins

|Jun 09, 2021
Viral Molecular Mimicry Influences the Antitumor Immune Response in Murine and Human Melanoma.

Jacopo Chiaro, Henna H E Kasanen, Thomas Whalley

|Feb 29, 2020
Exploiting Preexisting Immunity to Enhance Oncolytic Cancer Immunotherapy.

Siri Tähtinen, Sara Feola, Cristian Capasso

|Oct 24, 2019
Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy.

Leena Ylösmäki, Beatrice Polini, Sara Carpi

Pageof 2

Frequent Collaborators

6 joint publications

Sara Feola

6 joint publications

Vincenzo Cerullo

4 joint publications

Karita Peltonen

3 joint publications

Manlio Fusciello